We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NAVCO Pharmaceuticals Inc | TSXV:NAV | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 25.00% | 0.025 | 0.015 | 0.025 | 0.025 | 0.02 | 0.02 | 70,480 | 14:20:41 |
Pinetree Capital Ltd. (TSX:PNP) announces that as at February 28, 2014, Pinetree's unaudited net asset value per share ("NAV") was $0.92. NAV is calculated as at a particular date and is, by its nature, historical, and may not be reflective of Pinetree's future performance. Pinetree discloses an unaudited monthly NAV within 15 days after the month-end. The latest month-end NAV and more details about Pinetree and its investments can be found on Pinetree's website at www.pinetreecapital.com. Use of Non-GAAP Financial Measures NAV is a non-GAAP (general accepted accounting principles) measure calculated as the value of total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. There is no comparable GAAP measure presented in Pinetree's consolidated financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company has calculated NAV consistently for many years and believes that NAV can provide information useful to its shareholders in understanding its performance, and may assist in the evaluation of its business relative to that of its peers. About Pinetree Pinetree Capital Ltd. ("Pinetree") was incorporated under the laws of the Province of Ontario and its shares are publicly-traded on the Toronto Stock Exchange ("TSX") under the symbol "PNP". Pinetree is a diversified investment and merchant banking firm focused on the small cap market. Pinetree's investments are primarily in the following sectors: Precious Metals, Uranium and Technology. Pinetree's investment approach is to develop a macro view of a sector, build a position consistent with the view by identifying micro-cap opportunities within that sector, and devise an exit strategy designed to maximize our relative return in light of changing fundamentals and opportunities. Pinetree is recognized as a value added partner. FOR FURTHER INFORMATION PLEASE CONTACT: Pinetree Capital Ltd. Sheldon Inwentash, CPA, CA. Chairman & CEO 416-643-3884 Pinetree Capital Ltd. Gerry Feldman, CPA, CA CFO & Vice President, Corporate Development 416-643-3884 feldman@pinetreecapital.com Pinetree Capital Ltd. 130 King Street West, Suite 2500 Toronto, Ontario, Canada, M5X 2A2 www.pinetreecapital.com Investor Relations: Pinetree Capital Ltd. Richard Patricio, LL.B. Vice President, Legal and Corporate Affairs 416-941-9600 ir@pinetreecapital.com
1 Year NAVCO Pharmaceuticals Chart |
1 Month NAVCO Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions